SEC Form 4 · accession 0001140361-15-020648
WRIGHT MEDICAL GROUP INC · WMGI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William L. Griffin Jr.
Officer — SVP GM BioMimetic Therapeutics
Period of report
May 14, 2015
Accepted (ET)
May 18, 2015 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001137861
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 14, 2015 | S | 610 | $25.70 | D | 69,707 | D | |
| Common StockF1,F2 | May 15, 2015 | S | 712 | $26.38 | D | 68,995 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were sold pursuant to a Rule 10b5-1 plan to satisfy applicable withholding obligations upon vesting of restricted stock.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.38 to $26.3801 per share, inclusive. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price point upon request of the Securities and Exchange Commission staff, issuer, or a stockholder of issuer.